dupilumab
Regeneron,sanofi
['eosinophilic,esophagitis']
dupilumab safely and efficaciously improved clinical, histologic, endoscopic, and symptomatic measures of eosinophilic esophagitis, regardless of previous treatment with swallowed topical corticosteroids. #acg2022 #gastroenterology 
Trusted knowledge base of practical information and resources focused on gastroenterology medicine.